344 related articles for article (PubMed ID: 33091817)
1. Acute generalized exanthematous pustulosis with a focus on hydroxychloroquine: A 10-year experience in a skin hospital.
Nili A; Zarei E; Ghamari A; Farid AS; Tavakolpour S; Daneshpazhooh M; Mahmoudi H
Int Immunopharmacol; 2020 Dec; 89(Pt B):107093. PubMed ID: 33091817
[TBL] [Abstract][Full Text] [Related]
2. Prolonged pustular eruption from hydroxychloroquine: an unusual case of acute generalized exanthematous pustulosis.
Pearson KC; Morrell DS; Runge SR; Jolly P
Cutis; 2016 Mar; 97(3):212-6. PubMed ID: 27023083
[TBL] [Abstract][Full Text] [Related]
3. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
[TBL] [Abstract][Full Text] [Related]
4. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: first case report in Canada and review of the literature.
Bailey K; McKee D; Wismer J; Shear N
J Cutan Med Surg; 2013; 17(6):414-8. PubMed ID: 24138979
[TBL] [Abstract][Full Text] [Related]
5. The First Pediatric Case of Acute Generalized Exanthematous Pustulosis Caused by Hydroxychloroquine.
Liccioli G; Marrani E; Giani T; Simonini G; Barni S; Mori F
Pharmacology; 2019; 104(1-2):57-59. PubMed ID: 31067554
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine-induced acute generalized exanthematous pustulosis with positive patch-testing.
Charfi O; Kastalli S; Sahnoun R; Lakhoua G
Indian J Pharmacol; 2015; 47(6):693-4. PubMed ID: 26729969
[TBL] [Abstract][Full Text] [Related]
7. Delayed Presentation of Acute Generalized Exanthematous Pustulosis Following Treatment with Cefepime in a Patient with COVID-19 without the Use of Hydroxychloroquine.
Haraszti S; Sendil S; Jensen N
Am J Case Rep; 2020 Oct; 21():e926901. PubMed ID: 33097683
[TBL] [Abstract][Full Text] [Related]
8. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: a case with atypical clinical presentation.
Duman H; Topal IO; Kocaturk E; Cure K; Mansuroglu I
An Bras Dermatol; 2017; 92(3):404-406. PubMed ID: 29186260
[TBL] [Abstract][Full Text] [Related]
9. Acute generalized exanthematous pustulosis caused by hydroxychloroquine in a patient with rheumatoid arthritis and CARD14 mutation: Case report.
Luo F; Yuan XM; Xiong H; Chen CM; Ma WK; Yao XM
Medicine (Baltimore); 2023 Nov; 102(47):e36168. PubMed ID: 38013380
[TBL] [Abstract][Full Text] [Related]
10. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.
Lee HY; Chou D; Pang SM; Thirumoorthy T
Int J Dermatol; 2010 May; 49(5):507-12. PubMed ID: 20534083
[TBL] [Abstract][Full Text] [Related]
11. Acute generalized exanthematous pustulosis: clinical characteristics, etiologic associations, treatments, and outcomes in a series of 28 patients at Mayo Clinic, 1996-2013.
Alniemi DT; Wetter DA; Bridges AG; El-Azhary RA; Davis MD; Camilleri MJ; McEvoy MT
Int J Dermatol; 2017 Apr; 56(4):405-414. PubMed ID: 28084022
[TBL] [Abstract][Full Text] [Related]
12. A Case of Amoxicillin-Induced Acute Generalized Exanthematous Pustulosis Presenting as Septic Shock.
McDonald KA; Pierscianowski TA
J Cutan Med Surg; 2017; 21(4):351-355. PubMed ID: 28358593
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics, culprit drugs and outcome of patients with Acute Generalised Exanthematous Pustulosis seen in Hospital Sultanah Aminah, Johor Bahru.
Choon SE; Der YS; Lai NLJ; Yu SEE; Yap XL; Nalini NM
Med J Malaysia; 2018 Aug; 73(4):220-225. PubMed ID: 30121684
[TBL] [Abstract][Full Text] [Related]
14. Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus.
Tsurane K; Kaneko K; Yoshida K; Tanaka R; Sago H; Murashima A
Mod Rheumatol Case Rep; 2023 Jun; 7(2):373-377. PubMed ID: 36420890
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine.
Castner NB; Harris JC; Motaparthi K
Dermatol Ther; 2018 Sep; 31(5):e12660. PubMed ID: 30152569
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics, Disease Course, and Outcomes of Patients With Acute Generalized Exanthematous Pustulosis in the US.
Creadore A; Desai S; Alloo A; Dewan AK; Bakhtiar M; Cruz-Diaz C; Femia A; Fox L; Katz KL; Micheletti R; Nelson CA; Ortega-Loayza AG; Patrinely JR; Plovanich M; Rosenbach M; Shaigany S; Shields BE; Saleh JZ; Sharif-Sidi Z; Shinkai K; Smith J; Su C; Wanat KA; Wieser JK; Wright S; Noe MH; Mostaghimi A
JAMA Dermatol; 2022 Feb; 158(2):176-183. PubMed ID: 34985493
[TBL] [Abstract][Full Text] [Related]
17. [Drugs associated with acute generalized exanthematic pustulosis].
Saissi EH; Beau-Salinas F; Jonville-Béra AP; Lorette G; Autret-Leca E;
Ann Dermatol Venereol; 2003; 130(6-7):612-8. PubMed ID: 13679697
[TBL] [Abstract][Full Text] [Related]
18. The necessity of patch testing in determining the causative drug of AGEP.
Mofarrah R; Mofarrah R; Oshriehye M; Ghobadi Aski S; Nazemi N; Nooshiravanpoor P
J Cosmet Dermatol; 2021 Jul; 20(7):2156-2159. PubMed ID: 33190407
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine-induced acute generalized exanthematous pustulosis: a series of seven patients and review of the literature.
Chaabouni R; Bahloul E; Ennouri M; Atheymen R; Sellami K; Marrakchi S; Charfi S; Boudaya S; Amouri M; Bougacha N; Turki H
Int J Dermatol; 2021 Jun; 60(6):742-748. PubMed ID: 33598928
[TBL] [Abstract][Full Text] [Related]
20. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: three cases and a review of the literature.
Paradisi A; Bugatti L; Sisto T; Filosa G; Amerio PL; Capizzi R
Clin Ther; 2008 May; 30(5):930-40. PubMed ID: 18555940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
